Cargando…

Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study

Heart failure following acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Our previous observation that injection of apoptotic peripheral blood mononuclear cell (PBMC) suspensions was able to restore long-term cardiac function in a rat AMI model prompted us to study the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichtenauer, Michael, Mildner, Michael, Hoetzenecker, Konrad, Zimmermann, Matthias, Podesser, Bruno Karl, Sipos, Wolfgang, Berényi, Ervin, Dworschak, Martin, Tschachler, Erwin, Gyöngyösi, Mariann, Ankersmit, Hendrik Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228946/
https://www.ncbi.nlm.nih.gov/pubmed/21952733
http://dx.doi.org/10.1007/s00395-011-0224-6
_version_ 1782217889298776064
author Lichtenauer, Michael
Mildner, Michael
Hoetzenecker, Konrad
Zimmermann, Matthias
Podesser, Bruno Karl
Sipos, Wolfgang
Berényi, Ervin
Dworschak, Martin
Tschachler, Erwin
Gyöngyösi, Mariann
Ankersmit, Hendrik Jan
author_facet Lichtenauer, Michael
Mildner, Michael
Hoetzenecker, Konrad
Zimmermann, Matthias
Podesser, Bruno Karl
Sipos, Wolfgang
Berényi, Ervin
Dworschak, Martin
Tschachler, Erwin
Gyöngyösi, Mariann
Ankersmit, Hendrik Jan
author_sort Lichtenauer, Michael
collection PubMed
description Heart failure following acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Our previous observation that injection of apoptotic peripheral blood mononuclear cell (PBMC) suspensions was able to restore long-term cardiac function in a rat AMI model prompted us to study the effect of soluble factors derived from apoptotic PBMC on ventricular remodelling after AMI. Cell culture supernatants derived from irradiated apoptotic peripheral blood mononuclear cells (APOSEC) were collected and injected as a single dose intravenously after myocardial infarction in an experimental AMI rat model and in a porcine closed chest reperfused AMI model. Magnetic resonance imaging (MRI) and echocardiography were used to quantitate cardiac function. Analysis of soluble factors present in APOSEC was performed by enzyme-linked immunosorbent assay (ELISA) and activation of signalling cascades in human cardiomyocytes by APOSEC in vitro was studied by immunoblot analysis. Intravenous administration of a single dose of APOSEC resulted in a reduction of scar tissue formation in both AMI models. In the porcine reperfused AMI model, APOSEC led to higher values of ejection fraction (57.0 vs. 40.5%, p < 0.01), a better cardiac output (4.0 vs. 2.4 l/min, p < 0.001) and a reduced extent of infarction size (12.6 vs. 6.9%, p < 0.02) as determined by MRI. Exposure of primary human cardiac myocytes with APOSEC in vitro triggered the activation of pro-survival signalling-cascades (AKT, Erk1/2, CREB, c-Jun), increased anti-apoptotic gene products (Bcl-2, BAG1) and protected them from starvation-induced cell death. Intravenous infusion of culture supernatant of apoptotic PBMC attenuates myocardial remodelling in experimental AMI models. This effect is probably due to the activation of pro-survival signalling cascades in the affected cardiomyocytes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-011-0224-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3228946
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-32289462011-12-27 Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study Lichtenauer, Michael Mildner, Michael Hoetzenecker, Konrad Zimmermann, Matthias Podesser, Bruno Karl Sipos, Wolfgang Berényi, Ervin Dworschak, Martin Tschachler, Erwin Gyöngyösi, Mariann Ankersmit, Hendrik Jan Basic Res Cardiol Original Contribution Heart failure following acute myocardial infarction (AMI) is a major cause of morbidity and mortality. Our previous observation that injection of apoptotic peripheral blood mononuclear cell (PBMC) suspensions was able to restore long-term cardiac function in a rat AMI model prompted us to study the effect of soluble factors derived from apoptotic PBMC on ventricular remodelling after AMI. Cell culture supernatants derived from irradiated apoptotic peripheral blood mononuclear cells (APOSEC) were collected and injected as a single dose intravenously after myocardial infarction in an experimental AMI rat model and in a porcine closed chest reperfused AMI model. Magnetic resonance imaging (MRI) and echocardiography were used to quantitate cardiac function. Analysis of soluble factors present in APOSEC was performed by enzyme-linked immunosorbent assay (ELISA) and activation of signalling cascades in human cardiomyocytes by APOSEC in vitro was studied by immunoblot analysis. Intravenous administration of a single dose of APOSEC resulted in a reduction of scar tissue formation in both AMI models. In the porcine reperfused AMI model, APOSEC led to higher values of ejection fraction (57.0 vs. 40.5%, p < 0.01), a better cardiac output (4.0 vs. 2.4 l/min, p < 0.001) and a reduced extent of infarction size (12.6 vs. 6.9%, p < 0.02) as determined by MRI. Exposure of primary human cardiac myocytes with APOSEC in vitro triggered the activation of pro-survival signalling-cascades (AKT, Erk1/2, CREB, c-Jun), increased anti-apoptotic gene products (Bcl-2, BAG1) and protected them from starvation-induced cell death. Intravenous infusion of culture supernatant of apoptotic PBMC attenuates myocardial remodelling in experimental AMI models. This effect is probably due to the activation of pro-survival signalling cascades in the affected cardiomyocytes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00395-011-0224-6) contains supplementary material, which is available to authorized users. Springer-Verlag 2011-09-28 2011 /pmc/articles/PMC3228946/ /pubmed/21952733 http://dx.doi.org/10.1007/s00395-011-0224-6 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Contribution
Lichtenauer, Michael
Mildner, Michael
Hoetzenecker, Konrad
Zimmermann, Matthias
Podesser, Bruno Karl
Sipos, Wolfgang
Berényi, Ervin
Dworschak, Martin
Tschachler, Erwin
Gyöngyösi, Mariann
Ankersmit, Hendrik Jan
Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
title Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
title_full Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
title_fullStr Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
title_full_unstemmed Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
title_short Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
title_sort secretome of apoptotic peripheral blood cells (aposec) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228946/
https://www.ncbi.nlm.nih.gov/pubmed/21952733
http://dx.doi.org/10.1007/s00395-011-0224-6
work_keys_str_mv AT lichtenauermichael secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT mildnermichael secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT hoetzeneckerkonrad secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT zimmermannmatthias secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT podesserbrunokarl secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT siposwolfgang secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT berenyiervin secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT dworschakmartin secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT tschachlererwin secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT gyongyosimariann secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy
AT ankersmithendrikjan secretomeofapoptoticperipheralbloodcellsaposecconferscytoprotectiontocardiomyocytesandinhibitstissueremodellingafteracutemyocardialinfarctionapreclinicalstudy